Altimmune Announces Poster Presentation of HepTcell Program at 2017 Keystone Symposia Conference
Oct 26, 2016 12:32 pm UTC| Business
GAITHERSBURG, Md., Oct. 26, 2016 -- Altimmune, Inc., a clinical stage immunotherapeutic company, today announced that a poster detailing the design and preclinical evaluation of its HepTcell immunotherapeutic for the...
Oct 26, 2016 12:31 pm UTC| Business
SALT LAKE CITY, Oct. 26, 2016 -- Park City Group’s ReposiTrak®, the leading provider of Compliance Management and Track Trace solutions for food, pharma and dietary supplement safety, announces today that Karen...
AMSC to Report Second Quarter Financial Results on November 2, 2016
Oct 26, 2016 12:31 pm UTC| Business
DEVENS, Mass., Oct. 26, 2016 -- AMSC (NASDAQ:AMSC), a global solutions provider serving wind and power grid industry leaders, announced today that it plans to release its second quarter fiscal 2016 financial results...
Oct 26, 2016 12:30 pm UTC| Business
WALTHAM, Mass., Oct. 26, 2016 -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today...
Fulgent Genetics, Inc. to Announce Third Quarter 2016 Financial Results on November 3, 2016
Oct 26, 2016 12:06 pm UTC| Business
TEMPLE CITY, Calif., Oct. 26, 2016 -- Fulgent Genetics, Inc. (Nasdaq:FLGT) (“Fulgent Genetics” or the“company”) today announced that its third quarter 2016 financial results will be released after market close on...
Oct 26, 2016 12:05 pm UTC| Business
SAN FRANCISCO, Oct. 26, 2016 -- Flight attendants know how to travel. They visit routinely the cities we long to see, and they know their way around the world’s best airports. A newvideoby San Francisco International...
Argos Therapeutics Announces CEO Jeff Abbey Elected to NCBIO Board of Directors
Oct 26, 2016 12:05 pm UTC| Business
DURHAM, N.C., Oct. 26, 2016 -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis®...